IMM 1.64% 30.0¢ immutep limited

big buying stated , page-16

  1. 15,518 Posts.
    lightbulb Created with Sketch. 43
    Hi YMAV

    Yes I'm aware the poster presentation is being made by Dr. Goh, however it is under the auspices of the PRR trial group, and obviously reflects the outcome of the Phase 2b trial.

    I have to disagree with your point that the presentation will not talk about Cvac's positive effect on O.C. As per the release, PFS data will be one of the key results to be included.

    You'll have to forgive BB for being a bit over enthused, he's got a lot riding on PRR.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.